Pneumoconiosis treatment guidelines are primarily designed to manage the patient’s symptoms and provide the patient with the best possible quality of life. Pneumoconiosis is the term used to describe a class of lung diseases caused by breathing in various types of mineral dust. After being inhaled, these mineral dust particles get stuck in the lungs and cause inflammation that results in permanent scarring of the lung tissues.
Lung tissue scarring causes the lungs to harden, which in turn inhibits the ability of the lungs to exchange carbon dioxide and oxygen. There are three known types of pneumoconiosis. One type is a condition called black lung that is commonly caused by exposure to coal dust in mines and coal processing facilities.
The second type is silicosis, which is a disease that occurs from inhaling crystalline silica dust. The third disease in the pneumoconiosis family is known as siderosis, which is caused by the inhalation of iron particles. Although there is no current cure for any of the three types, there are pneumoconiosis treatment guidelines that you can follow that may help relieve symptoms of these diseases and possibly improve your quality of life.
Common Treatments Included in Pneumoconiosis Treatment Guidelines
The types of treatments used in pneumoconiosis treatment guidelines will vary from patient to patient. In fact, the types of treatments that are included in your personalized pneumoconiosis treatment guidelines are all designed to reduce the symptoms of the disease as much as possible and provide you with the highest possible quality of life. Some types of treatments that are typically included in pneumoconiosis treatment guidelines are:
- Medications, such as bronchodilators or inhaled corticosteroids
- Ensuring that you receive yearly vaccinations
- Promoting lifestyle changes that improve your quality of life
- Establishing helpful dietary and exercise goals
- Supplemental oxygen
While not all of these treatment types may be included in your pneumoconiosis treatment guidelines, each of them may have positive benefits for patients with pneumoconiosis.
Cellular Therapy Is a Treatment You Should Consider Adding to Your Pneumoconiosis Treatment Guidelines
One of the newer and more innovative treatments that you should consider adding to your pneumoconiosis treatment guidelines is cellular therapy. At the Lung Health Institute, our team recommends this procedure because of its potential to slow the progression of lung diseases like pneumoconiosis.
Cellular therapy has the benefits of being a minimally invasive procedure, being a two-day outpatient therapy and having the ability to potentially promote the natural healing of lung tissue and reduce inflammation. This procedure that you can include in your pneumoconiosis treatment guidelines has three steps, which are:
- The collection of a blood sample from the patient
- Separating platelets and white blood cells from other blood cells in a lab
- Reinserting the concentrated platelets and white blood cells into the patient’s bloodstream
For additional information about adding cellular therapy to your pneumoconiosis treatment guidelines or about other lung conditions, contact the team at the Lung Health Institute now.